Xeris Pharmaceuticals Inc (XERS) — Strategic Asset Allocation Index
Xeris Pharmaceuticals Inc (XERS) has a Strategic Asset Allocation Index of 765.6% as of September 2023. Strategic assets (PP&E of $29.59 Million plus long-term investments of $-) total $29.59 Million, measured against net assets of $3.87 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. For live market cap and overall valuation, see XERS market cap.
SAAI
Strategic Assets
PP&E
Net Assets
Xeris Pharmaceuticals Inc Strategic Asset Allocation Index (2018–2022)
This chart shows how Xeris Pharmaceuticals Inc's Strategic Asset Allocation Index has evolved across 5 annual periods from 2018 to 2022. As of September 2023, the index stands at 765.6%, representing strategic assets of $29.59 Million against net assets of $3.87 Million USD. See XERS net asset quality score to measure how much of total assets are equity-financed.
Annual Strategic Asset Allocation Index for Xeris Pharmaceuticals Inc (2018–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Xeris Pharmaceuticals Inc from 2018 to 2022, covering 5 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. Also explore Xeris Pharmaceuticals Inc net asset momentum to track the company's year-over-year net asset growth rate.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 21.0% | $9.51 Million | $9.51 Million | $- | $45.19 Million | ▲ +14.1 pp |
| 2021 | 7.0% | $6.63 Million | $6.63 Million | $- | $95.23 Million | ▼ -39.5 pp |
| 2020 | 46.5% | $6.71 Million | $6.71 Million | $0.00 | $14.44 Million | ▼ -99.6 pp |
| 2019 | 146.1% | $21.08 Million | $7.85 Million | $13.23 Million | $14.44 Million | ▲ +143.4 pp |
| 2018 | 2.7% | $2.03 Million | $2.03 Million | $- | $75.41 Million | — |